Complete Genomics Targets Larger Share of Services Market; Analysts Predict 21K Genomes in 2012
June 07, 2011
Complete Genomics Targets Larger Share of Services Market; Analysts Predict 21K Genomes in 2012
Complete Genomics' CEO predicted that the future of the complete human genome sequencing market is outsourcing. "We have both the technology and the business model set up to be the dominant player in the complete human genome sequencing market," he said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Despite Aggressive Pricing, Illumina Expects Outsourced Sequencing to Remain Small Part of Business
June 21, 2011 / In Sequence - Erasmus Orders 250 Genomes from Complete Genomics to Study Cancer, Congenital Malformations
May 24, 2011 / Clinical Sequencing News - Complete Aims for Clinical Market as it Readies its WG Haplotyping Tech for Launch
July 18, 2012 / Clinical Sequencing News - Complete Genomics Expects CLIA Certification This Year, Long Fragment Read Tech by 2013
May 9, 2012 / Clinical Sequencing News - Last Year's Production Delays Cause Slip in Complete Genomics' Q1 Revenues
May 8, 2012 / In Sequence